By


Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity

See more here

By


Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results

See more here

By


SIRPant Immunotherapeutics Announces FDA Clearance of IND Application for SIRPant-M™ Autologous SIRPαlow Activated Macrophage Immunotherapy

See more here

By


Treventis Partners its Preclinical Program in Alzheimer’s Disease with Takeda

See more here

By


Annovis Bio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

See more here

By


Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results

See more here